Diagnosis and Treatment > Signs and Symptoms

You are looking at 1 - 2 of 2 items for :

  • Erectile dysfunction x
Clear All
Kingsley Okolie National Health Co-op, Australian Capital Territory (ACT), Canberra, Australia

Search for other papers by Kingsley Okolie in
Google Scholar
PubMed
Close
,
Sumathy Perampalam Department of Endocrinology, Canberra Hospital, Canberra, ACT, Australia
Australian National University Medical School, Canberra, ACT, Australia

Search for other papers by Sumathy Perampalam in
Google Scholar
PubMed
Close
,
Anthony Barker Forensic Mental Health, Justice Health and Alcohol and Drug Services, Canberra, ACT, Australia

Search for other papers by Anthony Barker in
Google Scholar
PubMed
Close
, and
Christopher J Nolan Department of Endocrinology, Canberra Hospital, Canberra, ACT, Australia
Australian National University Medical School, Canberra, ACT, Australia

Search for other papers by Christopher J Nolan in
Google Scholar
PubMed
Close

Klinefelter syndrome (KS) is a chromosomal disorder affecting males, with the typical karyotype of 47,XXY due to a supernumerary X chromosome, which causes progressive testicular failure resulting in androgen deficiency and infertility. Despite it being the most common sex chromosomal disorder, its diagnosis is easily missed. In addition to its classical clinical features of tall stature, gynaecomastia, small testes, and symptoms and signs of hypogonadism including infertility, KS is also often associated with neurocognitive, behavioural and psychiatric disorders.

We present a 44-year-old man with KS who, despite having erectile dysfunction, paradoxically had increased libido. He used sildenafil to overcome his erectile dysfunction. Hypersexuality was manifested by very frequent masturbation, multiple sexual partners most of whom were casual, and a sexual offence conviction at the age of 17 years.

Discussion focuses on the frequent failure of clinicians to diagnose KS, the neurocognitive, behavioural and psychiatric aspects of KS, this unusual presentation of hypersexuality in a man with KS, and the challenges of medical management of hypogonadism in a man with a history of a sexual offence.

Learning points:

  • Klinefelter syndrome (KS) is common in men (about 1 in 600 males), but the diagnosis is very often missed.

  • In addition to classic features of hypogonadism, patients with KS can often have associated neurocognitive, behavioural and/or psychiatric disorders.

  • More awareness of the association between KS and difficulties related to verbal skills in boys could improve rates of early diagnosis and prevent longer-term psychosocial disability.

  • Hypersexuality in the context of hypogonadism raises the possibility of sex steroid independent mechanistic pathways for libido.

  • Testosterone replacement therapy in KS with hypersexuality should be undertaken with caution using a multidisciplinary team approach.

Open access
J Bukowczan Regional Pituitary Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK

Search for other papers by J Bukowczan in
Google Scholar
PubMed
Close
,
K Lois Regional Pituitary Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK

Search for other papers by K Lois in
Google Scholar
PubMed
Close
,
M Mathiopoulou Regional Pituitary Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK

Search for other papers by M Mathiopoulou in
Google Scholar
PubMed
Close
,
A B Grossman Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, OX3 7LE, UK

Search for other papers by A B Grossman in
Google Scholar
PubMed
Close
, and
R A James Regional Pituitary Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK

Search for other papers by R A James in
Google Scholar
PubMed
Close

Summary

Giant prolactinomas are rare tumours of the pituitary, which typically exceed 40 mm in their largest dimension. Impairment of higher cognitive function has been noted post-operatively after transcranial surgery and as a long-term consequence of the radiotherapy treatment. However, there has been little that is reported on such disturbances in relation to the tumour per se, and to our knowledge, there has been none in terms of responsivity to dopamine agonist therapy and shrinkage in these tumours. We present a case of successful restoration of severely impaired cognitive functions achieved safely after significant adenoma involution with medical treatment alone.

Learning points

  • Giant prolactinomas can be present with profound cognitive defects.

  • Dopamine agonists remain in the mainstay first-line treatment of giant prolactinomas.

  • Mechanisms of the reversible cognitive impairment associated with giant prolactinoma treatment appear to be complex and remain open to further studies.

  • Young patients with giant prolactinomas mandate genetic testing towards familial predisposition.

Open access